ContextVision AB is a Sweden-based medical technology software company specialized in image analysis and artificial intelligence. The Company is engaged in the image enhancement market and is a partner to the manufacturers of ultrasound, X-ray and Magnetic Resonance Imaging (MRI) equipment around the world. The Company develops software products, based on proprietary technology and artificial intelligence for image-based applications. ContextVisionâ€™s cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The Company operates through two separate segments: the Business Unit Medical Imaging and the Business Unit Digital Pathology. ContextVision has two subsidiaries: Inify Laboratories AB og ContextVision Inc.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

11-04 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
26-10-27	NOK 4.600	+3.14%	13,199
26-10-26	NOK 4.460	-0.67%	134,407
26-10-23	NOK 4.490	-3.44%	33,458
26-10-22	NOK 4.650	+1.53%	359,826
26-10-21	NOK 4.580	+0.66%	129,558

Real-time Oslo Bors

More quotes

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ContextVision AB

Company calendar

Real-time Oslo Bors 09:24:03 2026-10-27 EDT			5-day change	1st Jan Change
4.600 ^NOK	+3.14%		+1.10%	+8.49%

10-22	ContextVision Forms Partnership for Validation of Quantitative Imaging Technology	MT
10-22	Contextvision AB Signs Partnership Agreement with Linköping University, Region Östergötland, and the Center for Medical Image Science and Visualization for the Clinical Translation of Its Quantitative Imaging Portfolio	CI

Market Cap	355M 38.14M 34.1M 31.55M 28.57M 53.47M 3.63B 54.34M 380M 150M 1.9B 143M 140M 6.01B	P/E 2024	16.7x	P/E 2025	375x
Enterprise Value	298M 31.99M 28.61M 26.47M 23.96M 44.85M 3.04B 45.58M 318M 126M 1.59B 120M 118M 5.04B	EV / Sales 2024	2.67x	EV / Sales 2025	2.13x
Free-Float	33.31%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Oslo Bors	CONTX	Real-time
CBOE	COVo	Real-time
Nasdaq Stockholm	CONTXO	Delayed
CBOE	0L8Z	Real-time

10-22	ContextVision Forms Partnership for Validation of Quantitative Imaging Technology	MT
10-22	Contextvision AB Signs Partnership Agreement with Linköping University, Region Östergötland, and the Center for Medical Image Science and Visualization for the Clinical Translation of Its Quantitative Imaging Portfolio	CI
09-18	ContextVision AB (OB:CONTX) commences an Equity Buyback Plan for 2,000,000 shares for NOK 12 million, under the authorization approved on May 12, 2026.	CI
09-10	ContextVision to Launch Up to NOK12 Million Share Repurchase Program	MT
08-31	ContextVision AB, H1 2026 Earnings Call, Aug 27, 2026
08-27	ContextVision AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-13	ContextVision AB, Q1 2026 Pre Recorded Earnings Call, May 08, 2026
05-11	ContextVision AB 's Equity Buyback announced on September 15, 2025, has expired with	CI
05-08	Tranche Update on ContextVision AB (OB:CONTX)'s Equity Buyback Plan announced on September 15, 2025.	CI
05-08	ContextVision AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-08	ContextVision AB Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-07	ContextVision Terminates Market-making Deal with Norne Securities	MT
03-26	ContextVision and BeamWorks Partner to Advance Ai-Powered Quantitative Ultrasound Imaging Solutions	CI

ContextVision AB Stock

Stocks

CONTX

SE0014731154

Advanced Medical Equipment & Technology

Valuation: ContextVision AB

Chart: ContextVision AB

Latest news: ContextVision AB

Last Transcript: ContextVision AB

Analysts' recommendations: ContextVision AB

Press Releases: ContextVision AB

News in other languages: ContextVision AB

Quotes and Performance

Price Extremes

Managers and Directors: ContextVision AB

Latest insider transactions

Medical Software & Technology Services

Financials

Company Profile

Quotes

Quarterly revenue - Rate of surprise

25-05-07	Norne Securities downgrades Contextvision to hold (buy), target price NOK 5.50 - BN	FW
25-04-24	Norne Securities upgrades Contextvision to Buy (Hold), target price NOK 7 - BN	FW
25-02-25	Norne Securities downgrades Contextvision to Hold (Buy), target price NOK 7 - BN	FW
24-08-30	Today's stock recommendations at a glance	FW
24-08-30	Norne Securities lowers target price for Contextvision to NOK 6.50 (6.80), reiterates Hold - BN	FW

10-08	ContextVision AB: Transactions made under the buy-back programme	AQ
09-29	ContextVision AB: Transactions made under the buy-back programme	AQ
09-18	ContextVision AB: Transactions made under the buy-back programme	AQ
09-09	Initiation of share buyback program	AQ
08-27	ContextVision AB: Q2 interim report 2026 – Continued underlying growth and strengthened customer relationships in a stabilising market	AQ

1 day	+3.14%
1 week	+1.10%
Current month	-16.06%
1 month	-16.97%
3 months	+35.29%
6 months	+26.37%
Current year	+8.49%

1 week	4.14	4.8
1 month	4.14	5.78
Current year	2.7	5.78
1 year	2.7	5.78
3 years	2.7	9.2
5 years	2.7	24.4
10 years	2.7	30.9

Manager	Title	Age	Since
Gerald Pötzsch CEO	Chief Executive Officer	54	2022-07-31
Richard Hallström DFI	Director of Finance/CFO	-	2023-08-27
Marco Marien Voormolen CTO	Chief Tech/Sci/R&D Officer	-	2026-03-01

Director	Title	Age	Since
Martin Hedlund BRD	Director/Board Member	74	1996-12-31
Sven Günther-Hanssen BRD	Director/Board Member	72	2010-12-31
Knut Martin Henschen Ingvar BRD	Director/Board Member	71	2019-12-31

Date	Insider	Type	Main position	Quantity	% Market Cap.
2/20/23	Gerald Pötzsch	Buy	Chief Executive Officer	10,000	0.0129%
11/2/22	Gerald Pötzsch	Buy	Chief Executive Officer	10	0.0000%
11/2/22	Gerald Pötzsch	Buy	Chief Executive Officer	1,000	0.0013%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CONTEXTVISION AB	+3.14%	+1.10%	+3.84%	-36.99%	35.68M
THERMO FISHER SCIENTIFIC, INC.	-0.66%	+0.81%	+19.63%	+55.60%	253B
DANAHER CORPORATION	-1.02%	+3.81%	+4.47%	+20.29%	164B
INTUITIVE SURGICAL, INC.	-0.46%	+4.26%	-17.36%	+74.03%	157B
BOSTON SCIENTIFIC CORPORATION	-1.16%	+1.18%	-54.92%	-8.44%	66.06B
VEEVA SYSTEMS INC.	-0.94%	+0.44%	+8.59%	+67.34%	51.52B
SIEMENS HEALTHINEERS AG	-0.70%	+1.42%	-15.06%	-8.35%	52.64B
EDWARDS LIFESCIENCES CORPORATION	-0.45%	+3.83%	+19.00%	+44.25%	52.2B
AGILENT TECHNOLOGIES, INC.	-0.41%	+3.57%	+18.87%	+68.69%	49.61B
WATERS CORPORATION	+0.55%	+5.00%	+26.84%	+86.53%	44.8B
Average	-0.11%	+2.09%	+1.39%	+36.30%	89.05B
Weighted average by Cap.	-0.46%	+2.65%	+2.40%	+46.11%

	2024	2025
Net sales	131M 14.03M 12.55M 11.61M 10.51M 19.67M 1.33B 19.99M 140M 55.25M 698M 52.66M 51.53M 2.21B	110M 11.84M 10.59M 9.8M 8.87M 16.6M 1.13B 16.87M 118M 46.63M 589M 44.44M 43.49M 1.87B
Net income	24.68M 2.65M 2.37M 2.19M 1.98M 3.71M 252M 3.78M 26.38M 10.43M 132M 9.94M 9.73M 417M	787K 84.5K 75.56K 69.9K 63.29K 118K 8.04M 120K 841K 333K 4.2M 317K 310K 13.31M
Net Debt	-63.9M -6.86M -6.13M -5.68M -5.14M -9.62M -653M -9.78M -68.3M -27.02M -341M -25.75M -25.2M -1.08B	-57.24M -6.15M -5.5M -5.08M -4.6M -8.62M -585M -8.76M -61.18M -24.2M -306M -23.06M -22.57M -968M